Drug
Pramipexole clinical trials
Also written Mirapex and Sifrol®.
- studies test it
- 80
- open now
- 5
- in phase 3
- 26
- first study started
- 1998
Keep track of what changes. Save the Pramipexole studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
80 studies that test it; most in 2006 (13)
| Year | Studies |
|---|---|
| 1998 | 2 |
| 1999 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 4 |
| 2006 | 13 |
| 2007 | 7 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 5 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 12
- Phase 2
- 16
- Phase 3
- 26
- Phase 4
- 25
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 42 · Other 38
Boehringer Ingelheim (35) · Massachusetts General Hospital (3) · Region Skane (2) · National Institute of Mental Health (NIMH) (2) · Teva Pharmaceuticals USA (2) · Stanford University (2) · Clinical Academic Center (2CA-Braga) (2) · University of California, San Diego (1)
Often tested with
Tested in the same studies.
Rasagiline (2) · Bromocriptine (2) · Ropinirole (2) · Escitalopram (2) · Levodopa (2) · Carbidopa, levodopa drug combination (1) · Amisulpride (1) · Methylphenidate (1)
Studies
Open first, then newest update. How each study uses Pramipexole is read from its arms, and is right about nine times in ten.
Testing it · 80
- Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic DepressionRecruitingPhase 3Daniel LindqvistNCT07664852Written as Pramipexole
- Stratified Pharmacological Approaches for Regulating Circuit-Level EffectsRecruitingPhase 2Stanford UniversityNCT07022405Written as Pramipexole Immediate Release
- Precision Care for Major Depressive DisorderEnrolling by invitationPhase 4University of California, San FranciscoNCT06580041Written as Pramipexole
- Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD)RecruitingPhase 2Clinical Academic Center (2CA-Braga)NCT06611592Written as Pramipexole 0.088mg/tid
- Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant DepressionRecruitingPhase 4All India Institute of Medical Sciences, BhubaneswarNCT04936126Written as Pramipexole
- Pramipexole to Enhance Social ConnectionsActive, not recruitingPhase 2University of California, San DiegoNCT06269146Written as Pramipexole Pill
- A Study in Healthy People to Compare Two Tablet Formulations of PramipexoleCompletedPhase 1Boehringer IngelheimNCT07727785Written as Sifrol®
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVSuspendedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT06705478Written as Pramipexole ER
- Treating Leg Symptoms in Women With X-linked AdrenoleukodystrophyActive, not recruitingPhase 4Massachusetts General HospitalNCT05003648Written as Pramipexole
- Long-term Efficacy of Pramipexole in Anhedonic DepressionCompletedPhase 3Region SkaneNCT05825235Written as Pramipexole
- Pramipexole for Anhedonic DepressionCompletedPhase 3Region SkaneNCT05355337Written as Pramipexole
- Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUDTerminatedPhase 2/3Massachusetts General HospitalNCT04759703Written as Pramipexole
- Non-Opioid Pramipexole and PainCompletedEarly Phase 1University of New MexicoNCT03842709Written as Pramipexole Oral Tablet
- Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD)WithdrawnPhase 2Clinical Academic Center (2CA-Braga)NCT05401019Written as Pramipexole
- A Study in Patients With Major Depressive DisorderActive, not recruitingPhase 2Chase Therapeutics CorporationNCT03642964Written as CTC-501
- Social Decision Making in Parkinson's DiseaseCompletedPhase 1Vanderbilt University Medical CenterNCT04249544Written as Pramipexole
- A Phase 3 Study With P2B001 in Subjects With Early Parkinson'sCompletedPhase 3Pharma Two B Ltd.NCT03329508Written as Pramipexole 0.6 mg
- Pramipexole and Morphine for Renal ColicCompletedPhase 1/2East Carolina UniversityNCT04160520Written as Pramipexole
- a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by AntipsychoticsCompletedEarly Phase 1Shanghai Mental Health CenterNCT03430596Written as Pramipexole
- Pramipexole for Restless Leg Syndrome in Peritoneal Dialysis PatientsTerminatedPhase 4Dong JieNCT03817554Written as Pramipexole
See all 80 studies that test Pramipexole →
As the comparator · 9 — what is tested is compared with Pramipexole
- Safety, Tolerability, and Pharmacokinetics of DM1001 Transdermal Patch in Healthy Chinese ParticipantsNot yet recruitingPhase 1The Third Xiangya Hospital of Central South UniversityNCT07844954Written as Pramipexole Extended-Release Tablet
- A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.CompletedPhase 2Kissei Pharmaceutical Co., Ltd.NCT03845387Written as Pramipexole
- Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep DisturbanceCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00991276Written as pramipexole
- Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome PatientsCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00806026Written as pramipexol
- Bioequivalence Study of Two Formulations of Pramipexole Tablets 0.25 mgCompletedNot applicableDexa Medica GroupNCT02660060Written as Pramipexole Boehringer Ingelheim Pharma
- In Vitro/in Vivo Correlation (IVIVC) for Oral Slow Release (SR) Tablets Pramipexole in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02260024Written as Pramipexole IR tablets
- Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's DiseaseTerminatedPhase 4QualissimaNCT01048229Written as Pramipexole
- A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.TerminatedPhase 2Abbott ProductsNCT00903838Written as pramipexole
- SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson DiseaseCompletedPhase 3Solvay PharmaceuticalsNCT00335166Written as pramipexole
Codes
What other systems call Pramipexole · ClinicalTrials.gg INT006736
- MeSH (NLM) D000077487PramipexoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 83619PEU5TPRAMIPEXOLEConfirmed FDA, NLM, Wikidata
- RxNorm 746741Confirmed FDA, Wikidata
- Wikidata Q421304pramipexoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66456PramipexoleOne source FDA
- DrugBank DB00413One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077487 | Pramipexole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 83619PEU5T | PRAMIPEXOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 746741 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421304 | pramipexole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66456 | Pramipexole | One source FDA |
| DrugBank | DB00413 | — | One source Wikidata |
Also registered as pramipexole dihydrochloride (UNII 3D867NP06J · RxNorm 236747) and pramipexole dihydrochloride anhydrous (UNII 4R2HD0M28N).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.